Literature DB >> 33199901

COVID vaccine excitement builds as Moderna reports third positive result.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Vaccines

Mesh:

Substances:

Year:  2020        PMID: 33199901     DOI: 10.1038/d41586-020-03248-7

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  23 in total

1.  AIDS and COVID: A tale of two pandemics and the role of statisticians.

Authors:  Susan S Ellenberg; Jeffrey S Morris
Journal:  Stat Med       Date:  2021-05-20       Impact factor: 2.373

Review 2.  Current State of the First COVID-19 Vaccines.

Authors:  Birgit M Prüβ
Journal:  Vaccines (Basel)       Date:  2021-01-08

3.  Interim estimates in null models of COVID-19 vaccine effectiveness.

Authors:  Andreas Martin Lisewski
Journal:  Int J Infect Dis       Date:  2021-03-18       Impact factor: 3.623

Review 4.  Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.

Authors:  Ioannis P Trougakos; Kimon Stamatelopoulos; Evangelos Terpos; Ourania E Tsitsilonis; Evmorfia Aivalioti; Dimitrios Paraskevis; Efstathios Kastritis; George N Pavlakis; Meletios A Dimopoulos
Journal:  J Biomed Sci       Date:  2021-01-12       Impact factor: 8.410

5.  Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.

Authors:  Hu Zhu; Catherine Z Chen; Srilatha Sakamuru; Jinghua Zhao; Deborah K Ngan; Anton Simeonov; Mathew D Hall; Menghang Xia; Wei Zheng; Ruili Huang
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.996

6.  Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.

Authors:  Michael S Piepenbrink; Jun-Gyu Park; Fatai S Oladunni; Ashlesha Deshpande; Madhubanti Basu; Sanghita Sarkar; Andreas Loos; Jennifer Woo; Phillip Lovalenti; Derek Sloan; Chengjin Ye; Kevin Chiem; Christopher W Bates; Reuben E Burch; Nathaniel B Erdmann; Paul A Goepfert; Vu L Truong; Mark R Walter; Luis Martinez-Sobrido; James J Kobie
Journal:  Cell Rep Med       Date:  2021-02-25

7.  SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.

Authors:  Neha Vithani; Michael D Ward; Maxwell I Zimmerman; Borna Novak; Jonathan H Borowsky; Sukrit Singh; Gregory R Bowman
Journal:  bioRxiv       Date:  2020-12-10

8.  Willingness to vaccinate against COVID-19 in the US: Longitudinal evidence from a nationally representative sample of adults from April-October 2020.

Authors:  Michael Daly; Eric Robinson
Journal:  medRxiv       Date:  2020-11-30

Review 9.  Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review.

Authors:  Ramakant Yadav; Prashant K Bajpai; Dhiraj K Srivastava; Raj Kumar
Journal:  J Family Med Prim Care       Date:  2021-04-08

10.  Assessment of the knowledge, preferences and concern regarding the prospective COVID-19 vaccine among adults residing in New Delhi, India - A cross-sectional study.

Authors:  Farzana Islam; Rashmi Agarwalla; Meely Panda; Yasir Alvi; Vishal Singh; Arup Debroy; Arindam Ray; Amruta Vadnerkar; Shraddha Uttekar
Journal:  J Family Med Prim Care       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.